Corcept Therapeutics Inc (CORT)
55.92
-0.17
(-0.30%)
USD |
NASDAQ |
Nov 21, 16:00
55.96
+0.04
(+0.07%)
After-Hours: 20:00
Corcept Therapeutics Total Assets (Quarterly): 784.26M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 784.26M |
| June 30, 2024 | 714.56M |
| March 31, 2024 | 655.94M |
| December 31, 2023 | 621.52M |
| September 30, 2023 | 594.02M |
| June 30, 2023 | 524.62M |
| March 31, 2023 | 617.85M |
| December 31, 2022 | 583.43M |
| September 30, 2022 | 533.26M |
| June 30, 2022 | 496.36M |
| March 31, 2022 | 468.12M |
| December 31, 2021 | 423.76M |
| September 30, 2021 | 585.40M |
| June 30, 2021 | 568.48M |
| March 31, 2021 | 552.40M |
| December 31, 2020 | 571.73M |
| September 30, 2020 | 534.12M |
| June 30, 2020 | 497.82M |
| March 31, 2020 | 445.49M |
| December 31, 2019 | 412.31M |
| September 30, 2019 | 367.02M |
| June 30, 2019 | 328.68M |
| March 31, 2019 | 320.21M |
| December 31, 2018 | 311.69M |
| September 30, 2018 | 299.75M |
| Date | Value |
|---|---|
| June 30, 2018 | 274.38M |
| March 31, 2018 | 242.98M |
| December 31, 2017 | 220.54M |
| September 30, 2017 | 110.67M |
| June 30, 2017 | 86.54M |
| March 31, 2017 | 75.34M |
| December 31, 2016 | 68.75M |
| September 30, 2016 | 62.93M |
| June 30, 2016 | 56.84M |
| March 31, 2016 | 52.91M |
| December 31, 2015 | 51.90M |
| September 30, 2015 | 48.38M |
| June 30, 2015 | 48.36M |
| March 31, 2015 | 48.22M |
| December 31, 2014 | 34.63M |
| September 30, 2014 | 37.16M |
| June 30, 2014 | 44.39M |
| March 31, 2014 | 52.83M |
| December 31, 2013 | 63.08M |
| September 30, 2013 | 71.06M |
| June 30, 2013 | 79.69M |
| March 31, 2013 | 88.14M |
| December 31, 2012 | 99.17M |
| September 30, 2012 | 105.52M |
| June 30, 2012 | 38.62M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
412.31M
Minimum
Dec 2019
784.26M
Maximum
Sep 2024
559.27M
Average
560.44M
Median
Total Assets (Quarterly) Benchmarks
| Catalyst Pharmaceuticals Inc | 772.01M |
| Madrigal Pharmaceuticals Inc | 1.073B |
| ADMA Biologics Inc | 390.62M |
| Alnylam Pharmaceuticals Inc | 4.205B |
| Akebia Therapeutics Inc | 207.14M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 145.42M |
| Shareholders Equity (Quarterly) | 638.84M |
| Current Ratio | 3.700 |